Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience

BACKGROUND: Rituximab plus combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is broadly accepted as standard for the treatment of diffuse large B-cell lymphoma (DLBCL). Nevertheless, there is sparsely data concerning the management of elderly patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Schelker, Roland Christian, Herr, Wolfgang, Reichle, Albrecht, Vogelhuber, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195694/
https://www.ncbi.nlm.nih.gov/pubmed/30340554
http://dx.doi.org/10.1186/s12885-018-4885-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195694/
https://www.ncbi.nlm.nih.gov/pubmed/30340554
http://dx.doi.org/10.1186/s12885-018-4885-5

Ejemplares similares